Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 4/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 7/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20735955 | 0.96 | PDE10A (0.39) | USP2PDE10ACYP1A2PPARGMEN1 | |
| SCHEMBL20735933 | 0.94 | PDE10A (0.39) | USP2PDE10ACYP1A2PPARGMEN1 | |
| SCHEMBL20737306 | 0.93 | PDE10A (0.36) | USP2PDE10ACYP1A2MEN1KMT2A | |
| SCHEMBL20736523 | 0.92 | PDE10A (0.42) | USP2PDE10ACYP1A2PPARGMAPT | |
| SCHEMBL20737120 | 0.92 | PDE10A (0.40) | USP2PDE10ACYP1A2PPARGMEN1 | |
| SCHEMBL20737753 | 0.90 | PDE10A (0.39) | USP2PDE10ACYP1A2PPARGMEN1 | |
| SCHEMBL27250539 | 0.89 | USP2 (0.39) | USP2PDE10ACYP1A2PPARGMEN1 | |
| SCHEMBL20735956 | 0.89 | PDE10A (0.37) | PDE10ACYP1A2MEN1KMT2AMAPT | |
| SCHEMBL27250420 | 0.89 | USP2 (0.39) | USP2PDE10ACYP1A2PPARGMEN1 | |
| SCHEMBL27250576 | 0.88 | PDE10A (0.37) | USP2PDE10ACYP1A2PPARGMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12022728-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-11552251-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-10 | — | — | US | disclosed |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11552251-B2 | Organic electroluminescent element and electronic device | L1CAM, ESR1, LEF1 | USP2 4455/4885PDE10A 4099/4885CYP1A2 739/4885 |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | L1CAM, ESR1, LEF1 | USP2 4455/4885PDE10A 4099/4885CYP1A2 739/4885 |
| US-12022728-B2 | Organic electroluminescent element and electronic device | L1CAM, ESR1, LEF1 | USP2 4455/4885PDE10A 4099/4885CYP1A2 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.